Is Neuronetics, Inc. (STIM) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 87.4% / 30% | 19.7% / 30% | 25.7% / 30% | 2.51% / 5% | ✗ NOT HALAL |
| DJIM | 87.4% / 33% | 19.7% / 33% | 25.7% / 33% | 2.51% / 5% | ✗ NOT HALAL |
| MSCI | 58.6% / 33% | 13.2% / 33% | 17.2% / 33% | 2.51% / 5% | ✗ NOT HALAL |
| S&P | 87.4% / 33% | 19.7% / 33% | 25.7% / 33% | 2.51% / 5% | ✗ NOT HALAL |
| FTSE | 58.6% / 33% | 13.2% / 33% | 17.2% / 50% | 2.51% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 48.7% | |
| Operating Margin | -11.1% | |
| Net Margin | -26.1% | |
| Return on Equity (ROE) | -134.9% | |
| Return on Assets (ROA) | -13.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$20M |
| Free Cash Flow | -$21M |
| Total Debt | $90M |
| Debt-to-Equity | 344.1 |
| Current Ratio | 2.0 |
| Total Assets | $142M |
Price & Trading
| Last Close | $1.33 |
| 50-Day MA | $1.56 |
| 200-Day MA | $2.51 |
| Avg Volume | 2.0M |
| Beta | 0.9 |
|
52-Week Range
$0.80
| |
About Neuronetics, Inc. (STIM)
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Neuronetics, Inc. (STIM) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Neuronetics, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Neuronetics, Inc.'s debt ratio?
Neuronetics, Inc.'s debt ratio is 87.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 58.6%.
What are Neuronetics, Inc.'s key financial metrics?
Neuronetics, Inc. has a market capitalization of $89M, and revenue of $149M. The company maintains a gross margin of 48.7% and a net margin of -26.1%. Return on equity stands at -134.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.